Compugen Ltd.
CGEN
Positions held
Your positionsCGEN isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $200.82M | Enterprise value | $78.54M | Trailing P/E | 5.58 | Forward P/E | -5.78 |
| PEG | 1.29 | Price / book | 2.26 | Beta | 2.79 | Dividend yield | 0.00% |
| Revenue growth | 107.0% | Earnings growth | — | Gross margin | 86.9% | Operating margin | -3.4% |
| Profit margin | 47.6% | ROE | 50.6% | ROA | 15.5% | Debt / equity | 0.03 |
| Current ratio | 5.72 | Free cash flow | $22.22M | Analyst recommendation | strong_buy | Mean target | $4.60 |
| 52w high | $3.24 | 52w low | $1.43 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6M | $2.2M | $67.3M | $1.9M | $1.3M | — |
| Op margin | -339.6% | -414.4% | 83.2% | -417.4% | -670.6% | — |
| Net income | -$7.0M | -$7.7M | $56.8M | -$7.0M | -$7.3M | — |
| Gross margin | -3.5% | 16.2% | 94.7% | 12.7% | -32.5% | — |
| Gross profit | -$0.1M | $0.4M | $63.8M | $0.2M | -$0.4M | — |
| Operating income | -$8.8M | -$9.0M | $56.0M | -$7.9M | -$8.4M | — |
- Revenue +20% vs prior quarter ($2.6M vs $2.2M).
- Gross margin -3.5% (was 16.2% prior quarter).
- Operating margin expanded to -339.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $72.8M | $27.9M | $33.5M | $7.5M | — |
| Op margin | 43.1% | -53.4% | -38.8% | -471.7% | — |
| Net income | $35.3M | -$14.2M | -$18.8M | -$33.7M | — |
| Gross margin | 87.3% | 71.5% | 94.0% | 87.0% | — |
| Gross profit | $63.5M | $19.9M | $31.5M | $6.5M | — |
| Operating income | $31.3M | -$14.9M | -$13.0M | -$35.4M | — |
Headlines — positive tone
• [OK · fundamentals] All You Need to Know About Compugen (CGEN) Rating Upgrade to Buy
News
2026-10-05 · Compugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor Targets
2026-09-22 · Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026
2026-09-08 · Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-31 · All You Need to Know About Compugen (CGEN) Rating Upgrade to Buy
2026-08-21 · Are Medical Stocks Lagging Compugen (CGEN) This Year?
2026-08-06 · Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ...
2026-08-04 · Compugen Ltd. Q2 2026 Earnings Call Summary
2026-08-03 · Compugen Q2 Earnings Call Highlights
2026-08-03 · Compugen: Q2 Earnings Snapshot
2026-08-03 · Compugen Reports Second Quarter 2026 Results
2026-07-31 · Earnings To Watch: Compugen Ltd (CGEN) Reports Q2 2026 Result
Price (daily)
Full chart · RSI · MACD · patterns